Valles Ophthalmology Research S.L.
- Address
- Carrer Pedro I Pons 1, 08195 Sant Cugat del Vallès, Spain
Valles Ophthalmology Research S.L. - Advanced Retinal Disease Research Center
Valles Ophthalmology Research S.L. is a specialized clinical research center dedicated to advancing treatments for complex retinal and ophthalmologic conditions. The center demonstrates particular expertise in evaluating novel therapeutic approaches for age-related macular degeneration and its complications, with extensive experience in both intravitreal and subcutaneous drug delivery systems.
- Geographic atrophy and dry age-related macular degeneration, including complement pathway inhibition and mitochondrial protection therapies
- Diabetic macular edema with focus on anti-VEGF and novel intravitreal therapeutic comparisons
- Rare retinal vascular conditions such as polypoidal choroidal vasculopathy
- Thyroid eye disease and autoimmune ophthalmologic disorders
The research center's portfolio reflects a comprehensive approach to investigating complement inhibition pathways, anti-VEGF therapeutics, and emerging treatment modalities for preserving visual function. With participation in multiple Phase III and IV trials, Valles Ophthalmology Research demonstrates capability in evaluating both long-term safety extensions and comparative efficacy studies, positioning the center at the forefront of retinal disease research and innovation in visual acuity preservation strategies.
Site Overview
Activity Indicator
Last 6 months
Trial Flow
How this site's trials are distributed across therapeutic areas and active substances (IMPs), and how they're positioned within their overall lifecycle status. Flow thickness represents the number of unique trials.
Compounds & Molecules Timeline
The time span of clinical-trial activity for the main active substances (IMPs) studied at this site over the last 8 years. Each bar runs from the earliest trial start to the most recent end; a substance with a trial still open has no recorded end and is shown as ongoing.
Sponsor & Partnership
Top sponsors by active trials, and the ones that have come back for more than one study.
Sponsor Network
Top 2 by active trials.
- 1Eyebiotech Limited1active
lock +1 more on a paid plan
Partnership History
Sponsors with repeated collaboration (≥ 2 trials).
- 1Eyebiotech Limited3trials
Sponsor Network Graph
How sponsors and therapeutic areas connect across this site's active trials: each link is at least one active trial shared between them, and bigger nodes mean more activity. Click a node to see its exact connections.
Country Benchmark
Compared to 567 other sites in Spain
Therapeutic Area Benchmark — Spain
Select a therapeutic area to compare against other sites in Spain.
Competitor Comparison
Similar sites in the same country running a comparable number of trials (within ±30%), scored on how closely their trial portfolios match this one. Higher percentages mean a more similar profile.
Country: Spain
Market Share
Country: Spain
Therapeutic Area Market Share
Select a therapeutic area to view its disease coverage breakdown.
Heat Maps & Advanced Analytics
How often specific conditions appear in trials across this site and comparable sites from the same country. Each row is a site, each column a condition, and each cell the number of trials on it — darker means more activity.
Other Trials in Valles Ophthalmology Research S.L.
lock Showing 1 of 8 trials — the rest is available on a paid plan.
| Trial | Sponsor | Phase | Status | Start Date | End Date |
|---|---|---|---|---|---|
| Efficacy and Safety Evaluation of Efgartigimod PH20 SC in Adults with Thyroid Eye Disease: A Phase 3 Randomized, Double-Masked, Placebo-Controlled Study | Argenx | Phase III | Not Recruiting | Oct 2024 | Dec 2025 |
IMP list
lock Showing 1 of 9 compounds — the rest is available on a paid plan.
| IMP | Trials | Status | First start | Last start |
|---|---|---|---|---|
| Fluorescein Sodium | 4 | Unknown | 2022-12-21 | 2026-06-22 |
Request feasibility information
Ask this centre about capacity, equipment and patient population.
Upgrade this site to Business Plan
Own the profile, publish your feasibility data and reach sponsors directly.
Is something out of date?
Tell us what needs correcting and we'll update this profile.
lock Available to Business plan sites only.